Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 8,213 shares at $38.99 ($325K) on 2020-06-08, disclosed to the SEC on 2020-06-10.
Open-market sale of $325k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.99 | 1,963 | $77K | 23.6% |
| 2 | $38.99 | 1,963 | $77K | 23.6% |
| 3 | $39.59 | 120 | $5K | 1.5% |
| 4 | $40.00 | 4,167 | $167K | 51.4% |
| Total | $39.51 avg | 8,213 | $325K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |